About MHL
MHL is a Healthcare company based in Chandigarh (India) founded in 2017. Its chief executive, as recorded, is Sumeet Gupta. Its Indian entity Muffin Health & Lifestyle Private Limited reported revenue of ₹47.5 Lakh. MHL offers products and services including Malaria Vaccine, COVID-19 Vaccine, Dengue Vaccine, Influenza Vaccine, and Nanoparticles. Its focus areas include Life Sciences, Infectious Diseases, Drugs and Diversified. Its competitors include Biological E and Serum Institute of India.
Company details
Developer of nanoparticles and vaccines for infectious diseases. The company focuses on design, synthesis, characterization of lipid- and polymer-based nanostructured biomaterials for the treatment of infectious diseases such as Malaria and COVID-19.
- Headquarters Chandigarh, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website mhlcare.com
- Legal Name Muffin Health & Lifestyle Private Limited
- Date of Incorporation 04 Jul, 2017
- Jurisdiction Chandigarh, India
- Annual Revenue₹47.5 Lakh
FY 2025
- Net Loss-₹2.2 Lakh
FY 2025 · -5% margin
- EBITDA-₹2.2 Lakh
FY 2025 · -5% margin
Associated legal entities of MHL
MHL operates through Muffin Health & Lifestyle Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Muffin Health & Lifestyle Private Limited CIN U24304CH2017PTC041625 | Active | 04 Jul 2017 | Chandigarh, Chandigarh | ₹0.5 Cr | 3 | View details |
Products & Services of MHL
MHL offers a comprehensive portfolio of products and services, including Malaria Vaccine, COVID-19 Vaccine, Dengue Vaccine, Influenza Vaccine, and Nanoparticles.
Vaccine aimed at preventing and treating Malaria infections.
Vaccine for combating COVID-19 and related variants.
Vaccine targeting Dengue fever prevention.
Vaccine for influenza protection and management.
Materials used in healthcare for drug delivery applications.
Board of directors of Muffin Health & Lifestyle Private Limited (MHL)
Muffin Health & Lifestyle Private Limited is the primary company behind MHL. The board of Muffin Health & Lifestyle Private Limited currently have 3 directors; the longest-serving is Brijesh Gupta, appointed in 2017. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Brijesh Gupta DIN 01174549 | Director | 04 Jul 2017 | 9 yrs 3 mo | Muffin Health & Lifestyle Private Limited |
| Anita Rani DIN 07840813 | Director | 04 Jul 2017 | 9 yrs 3 mo | Muffin Health & Lifestyle Private Limited |
| Om Parkash DIN 07840790 | Director | 04 Jul 2017 | 9 yrs 3 mo | Muffin Health & Lifestyle Private Limited |
People of MHL
1 people are tracked at MHL (1 in leadership).
| Name | Role | Group |
|---|---|---|
Sumeet Gupta | CEO | Leadership |
Complete people profiles for MHL
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of MHL
Figures of Muffin Health & Lifestyle Private Limited, the primary company behind MHL, for FY 2025. Revenue was ₹47.5 Lakh. Net loss was -₹2.2 Lakh (-5% margin). EBITDA was -₹2.2 Lakh (-5% margin).
- ₹47.5 LakhRevenue · FY 2025
- -₹2.2 LakhNet loss · -5% margin
- -₹2.2 LakhEBITDA · -5% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Muffin Health & Lifestyle Private Limited are on its company page.
Detailed financial statements for MHL
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of MHL
MHL has 2 listed competitors in our database. They include Biological E and Serum Institute of India.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biologicale.com | 1953 | Hyderabad, India | 6,099 | Vaccines and therapeutics for multiple diseases are developed and marketed. | ||
| seruminstitute.com | 1966 | Pune, India | 6,617 | Vaccines and immuno-biological drugs for infectious diseases are manufactured. |
Detailed competitors of MHL
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MHL
MHL was founded in 2017.
MHL is headquartered in Chandigarh, India.
Sumeet Gupta is the CEO of MHL, as recorded in our data.
The primary company behind MHL, Muffin Health & Lifestyle Private Limited, reported revenue of ₹47.5 Lakh for FY 2025.
Developer of nanoparticles and vaccines for infectious diseases. The company focuses on design, synthesis, characterization of lipid- and polymer-based nanostructured biomaterials for the treatment of infectious diseases such as Malaria and COVID-19.
MHL's top competitors include Serum Institute of India and Biological E.
MHL offers Malaria Vaccine, COVID-19 Vaccine, Dengue Vaccine, Influenza Vaccine, and Nanoparticles.
MHL operates through Muffin Health & Lifestyle Private Limited.
The legal entities of MHL currently have 3 directors, including Brijesh Gupta, Anita Rani, Om Parkash.